申请人:Miura Toru
公开号:US20120225896A1
公开(公告)日:2012-09-06
Disclosed is a novel 2-pyridone derivative represented by general formula (1), which has both angiotensin II receptor antagonist activity and PPAR-γ activating activity and is useful as a prophylactic and/or therapeutic agent for cardiovascular diseases and metabolic diseases. Also disclosed is a pharmaceutical composition which contains the novel 2-pyridone derivative. In general formula (1), R
1
represents a C
1-6
alkyl group or a C
1-6
alkoxy group; R
2
represents a C
1-6
alkyl group or a C
3-8
cycloalkyl group; R
3
represents a C
1-6
alkyl group, a C
6-10
aryl-C
1-6
alkyl group, a C
1-6
alkoxy-C
1-6
alkyl group or a group represented by formula (2) (wherein A represents a nitrogen atom or CH, and R
5
represents a hydrogen atom or a C
1-6
alkoxy group); and R
4
represents a group represented by formula (3) or (4).
揭示了一种由通式(1)表示的新型2-吡啶酮衍生物,该衍生物具有抗血管紧张素II受体拮抗活性和PPAR-γ激活活性,并且可用作心血管疾病和代谢性疾病的预防和/或治疗剂。还揭示了一种含有该新型2-吡啶酮衍生物的药物组合物。在通式(1)中,R1代表C1-6烷基或C1-6烷氧基;R2代表C1-6烷基或C3-8环烷基;R3代表C1-6烷基、C6-10芳基-C1-6烷基、C1-6烷氧基-C1-6烷基或由通式(2)表示的基团(其中A代表氮原子或CH,R5代表氢原子或C1-6烷氧基);R4代表由通式(3)或(4)表示的基团。